Question 1

- question: "How does ketamine work as an antidepressant?

Accepted Answer

Ketamine blocks N-methyl-D-aspartate (NMDA) glutamate receptors in the brain. This blockade triggers a surge of glutamate signaling at AMPA receptors, which activates a cascade of molecular events including increased brain-derived neurotrophic factor (BDNF) release and activation of the mechanistic target of rapamycin (mTOR) pathway. These processes rapidly promote the formation of new synaptic connections in brain regions involved in mood regulation, particularly the prefrontal cortex and hippocampus. This mechanism is fundamentally different from traditional antidepressants that target serotonin and norepinephrine systems.

Question 2

Why does ketamine work so much faster than traditional antidepressants?

Accepted Answer

Traditional antidepressants increase monoamine levels in the synapse, but therapeutic effects require weeks of gradual downstream receptor adaptations and slow-building neurotrophic signaling. Ketamine bypasses this process entirely by directly triggering rapid synaptogenesis through the glutamate-BDNF-mTOR pathway. New dendritic spines can form within hours, restoring synaptic connections that were lost during chronic stress and depression. This speed of molecular action translates directly into rapid clinical improvement.

Question 3

What is the difference between ketamine and esketamine?

Accepted Answer

Ketamine is a racemic mixture containing two mirror-image molecules: S-ketamine (esketamine) and R-ketamine (arketamine). Esketamine, the purified S-enantiomer, has approximately 3 to 4 times greater affinity for the NMDA receptor and was developed as Spravato (intranasal spray) by Janssen Pharmaceuticals, receiving FDA approval in 2019. Racemic ketamine contains both enantiomers and is used off-label. Some researchers believe arketamine contributes additional antidepressant properties through mechanisms beyond NMDA blockade.

Question 4

Does ketamine permanently change the brain?

Accepted Answer

Ketamine promotes neuroplasticity, forming new synaptic connections that can persist beyond the acute drug effects. However, without ongoing treatment or complementary interventions, these new connections may be pruned over time. This is why maintenance treatments are typically needed. The combination of ketamine with psychotherapy may help consolidate neural changes by actively utilizing new synaptic pathways during the plasticity window that ketamine creates. Long-term structural changes have not been demonstrated at therapeutic dose frequencies.

Question 5

Is ketamine's antidepressant effect related to the dissociative experience?

Accepted Answer

This is an active area of research. Early studies suggested a correlation between dissociative intensity and antidepressant response, leading to the hypothesis that the psychological experience contributes to therapeutic benefit. However, more recent research has shown that antidepressant effects can occur at sub-dissociative doses, and some studies have not found a consistent correlation. The current consensus is that the neurobiological mechanism (NMDA blockade and downstream signaling) drives the antidepressant effect, though the subjective experience may contribute through psychological mechanisms in some patients.

Question 6

What is neuroplasticity and why does it matter for depression?

Accepted Answer

Neuroplasticity refers to the brain's ability to form new neural connections and reorganize existing ones. Chronic stress and depression are associated with synaptic atrophy — a loss of dendritic spines and synaptic connections — particularly in the prefrontal cortex, which governs executive function and emotional regulation. Treatments that restore these connections can reverse depressive symptoms. Ketamine's ability to rapidly promote synaptogenesis is considered a primary mechanism of its antidepressant effect, essentially rebuilding the neural infrastructure that depression has degraded.

How Ketamine Works: Science FAQ

Frequently Asked Questions

Related Reading

Is Ketamine a Controlled Substance? Schedule III Status Explained

Getting Started with Ketamine Therapy

What Are the Common Side Effects of Ketamine?